NOT FOR PUBLIC DISTRIBUTION, DIRECTLY OR INDIRECTLY,
IN OR INTO AUSTRALIA, CANADA, JAPAN OR OTHER
RESTRICTED TERRITORIES
Reference is made to the offer document dated 18
September 2013 (the "Offer Document") regarding the
mandatory offer made by Merckx AS ("Merckx" or
the "Offeror") to acquire all outstanding shares in
Blom ASA ("Blom" or the "Company") that are not
already owned by the Offeror, at an offer price of
NOK 0.10 per share (the "Offer").
The acceptance period of the Offer expired today, 17
October 2013, at 16:30 CET.
The preliminary result of the Offer shows that the
Offeror has received acceptance of the Offer for a
total of 8,588,088 shares in the Company,
representing approximately 25.5% of the issued shares
in the Company. There may be adjustments to the
preliminary result. The final result of the Offer
will be announced at settlement of the Offer.
Together with the 12,283,969 shares already held by
the Offeror in the Company, the Offeror will, at
completion of the Offer, hold 20,872,057 shares in
the Company, representing 61.9% of all the issued
shares of the Company.
In accordance with the terms and conditions set out
in the Offer Document, settlement according to the
Offer will take place as soon as possible and no
later than on 31 October 2013. On the settlement
date, the shares in the Company accepted and sold
under this Offer will be transferred to the Offeror
against consideration payable in cash. Settlement
will be made in Norwegian Kroner (NOK).
ABG Sundal Collier Norge ASA is acting (solely) as
receiving agent for Merckx in relation to the Offer.
Tenden Advokatfirma ANS is acting as legal advisor to
Merckx in relation to the Offer.
The Offeror is represented at the board of the
Company through Tore Hopen, Kristian Gjertsen
Lundkvist and Birgitte Askjem Ellingsen, and the
Offeror is thus to be considered a primary insider of
Blom for the purposes of mandatory notifications
of trades.
Tønsberg, 17 October 2013
Contact:
Tore Hopen, Chairman of the Board in Merckx
Telephone: +47 93 48 06 07
***
The Offer and the distribution of this announcement
and other information in connection with the Offer
may be restricted by law in certain jurisdictions.
Merckx does not assume any responsibility in the
event there is a violation by any person of such
restrictions. Persons into whose possession this
announcement or such other information should come
are required to inform themselves about and to
observe any such restrictions.